A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
For the first time in India – fast, precise and efficient calibration of multi-channel micropipettes
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
The company exports mobile surgery equipment to over 100 countries from Pune
Cipla has reported consolidated financial results for the period ended March 31, 2022
The partners also aim to expand their work to Latin America for the first time
Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
RNA extraction free kit to deliver results in just 45 minutes
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
Subscribe To Our Newsletter & Stay Updated
